InvestorsHub Logo
Followers 10
Posts 299
Boards Moderated 0
Alias Born 07/13/2012

Re: None

Wednesday, 04/08/2020 9:36:22 PM

Wednesday, April 08, 2020 9:36:22 PM

Post# of 73656
I’ll give credit where credit is due! I received this e-mail from Mr. Hartman. I asked him about revenues, positive performance and an update with the FDA. Here’s his response:

Thank you for your interest in Premier Biomedical. We do plan to issue an entire series of press releases and CEO letters addressing these and other issues. In obedience of the law, I cannot advise you of issues that are not in the public domain. i can say that we will be the recipient of income from some of our partners as well as possible expansion of our line of hemp oil products. The latter depends on availability of revenus from our partners as well as private placement investors. We are pursuing both domestic and off-shore entities to fund these plans. We are also in negotiations to expand our sales force of our hemp oil product lines. We will keep investors up to date via periodic CEO letters.

William A. Hartman
President/CEO
Premier Biomedical, Inc.
Office: (814) 786-8849
Skype: w.a.hartman
www.premierbiomedical.com
www.painreliefmeds.com